Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2006
10/25/2006CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/25/2006CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/24/2006US7126006 Substituted amine radical as building blocks; increases structural diversity
10/24/2006US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006US7125989 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene
10/24/2006US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006US7125874 Optically active 5H-pyrrolo[3,4-b] pyrazine derivative, its preparation and pharmaceutical compositions containing same
10/24/2006US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006US7125862 Porphyrin-metal complexes and oxygen infusions containing the same
10/24/2006US7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/24/2006CA2211411C Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides
10/24/2006CA2167584C Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
10/19/2006WO2006110298A2 8-alkyl/aryl-4-aryl-2-n- (alkylamino)-n'-substituted-n'-cyanoguanidino-8h-pyrido[2,3-d]pyrimidin-7-one compounds and use thereof
10/19/2006WO2006110025A1 Qualitative and quantitative analyses of small molecules
10/19/2006WO2006108489A1 Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
10/19/2006WO2006108488A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
10/19/2006WO2006069395A3 Synthetic process for the preparation of biocyclic compounds
10/19/2006US20060235223 Variolin derivatives and their use as antitumor agents
10/19/2006US20060235065 e.g 3-(7,7-Dimethyl-6-oxo-1,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl)-1H-pyrazol-4-yl]-carbamic acid benzyl ester; Aurora A (serotonin/threonine) kinase inhibitors; anticarcinogenic agent; colorectal, breast, lung, prostate, pancreatic, gastric, bladder, ovarian cancer, melanoma, neuroblastoma
10/19/2006US20060235060 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
10/19/2006US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006US20060235031 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors
10/19/2006US20060235030 Novel compounds
10/19/2006US20060235029 Novel compounds
10/19/2006US20060235025 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/19/2006US20060235019 Substituted quinazolinone compounds
10/19/2006US20060235014 Inhibitors of p38
10/19/2006US20060235013 Tricyclic azole derivatives
10/19/2006US20060234999 Natural, synthetic or semi-synthetic crude harringtonines purified by chromatography and crystallization in which the solvent is water or lower C1-4 alkanol or an aqueous mixture of organic solvents; treatment of cancer through oral administration
10/19/2006US20060234983 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
10/19/2006US20060234324 Calcium-binding photoprotein, coelenterazine and imidazole compound which removes NH-proton of pyrazine ring of imidazopyrazine
10/19/2006US20060233719 Delivery of antidepressants through an inhalation route
10/19/2006DE112004001502T5 Neurobeschützende und Anti-Proliferationsverbindungen Neurobeschützende and anti-proliferative compounds
10/19/2006DE102005018024A1 New benzazepine stereoisomeric compounds useful as glucocorticoid receptor inhibitors to treat e.g. inflammatory diseases, atopic dermatitis, tumors and eye diseases
10/19/2006CA2603204A1 Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
10/19/2006CA2602303A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
10/18/2006EP1712553A2 Derivates of [6, 7-dihydro - 5H - imidazo[1,2- alpha]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of CAMS and leukointegrins
10/18/2006EP1712549A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
10/18/2006EP1711504A2 Derivatives of cephalosporin and clavulanic acid for detecting beta-lactamase in a sample
10/18/2006EP1711501A2 Process for the synthesis of n- [3-(3-cyanopyrazolo [1,5a] pyrimidin-7-yl)-phenyl] -n-ethyl-acetamide
10/18/2006EP1711500A1 Diaza- or thiazadione derivatives with neuroprotective activity
10/18/2006EP1711499A2 Fused pyrrolocarbazoles and methods for the preparation thereof
10/18/2006EP1711488A1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof
10/18/2006EP1711487A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2006EP1711463A2 Amino-substituted tricyclic derivatives and methods of use
10/18/2006EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
10/18/2006EP1711174A1 Adjuvant compositions
10/18/2006EP1506199B1 A process for the preparation of zaleplon
10/18/2006CN1849321A Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
10/18/2006CN1849315A Novel amides useful for treating pain
10/18/2006CN1849308A Thiophenylaminoimidazolines
10/18/2006CN1849070A 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
10/18/2006CN1847247A 'One kettle process' of preparing cefozopran and its intermediate
10/18/2006CN1847245A Process of preparing sodium-copper chlorophyllide and pectin with sisal residue
10/18/2006CN1847244A Polymorphs of zaleplon and methods for the preparation thereof
10/18/2006CN1280271C Arylphenyl-substituted cyclic keto-enols
10/18/2006CN1279907C Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
10/17/2006US7122695 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
10/17/2006US7122679 Multicyclic compounds and the use thereof
10/17/2006US7122673 Cyclization of imines to form compounds such as 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one, used as nontoxic modulators of multidrug resistant cells; antitumor agents
10/17/2006US7122666 Antiinflammatory agents; autoimmune disease; antiarthritic agents
10/17/2006US7122665 Heterocyclic compounds
10/17/2006US7122664 Cucurbituril-fullerene complex
10/17/2006US7122663 Oxidation of alcohols to aldehydes, ketones, acids
10/17/2006US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
10/17/2006US7122569 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative; ethylene glycol esters of monohydrobenzoporphyrins
10/17/2006US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006US7122548 Triazolotriazine compounds and uses thereof
10/17/2006US7122545 Imidazo-benzothiazoles
10/17/2006US7122540 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
10/17/2006US7122526 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione
10/17/2006CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/17/2006CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists
10/17/2006CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
10/17/2006CA2226669C Herbicidal sulphonylamino(thio)carbonyl compounds
10/12/2006WO2006108103A1 Purine and imidazopyridine derivatives for immunosuppression
10/12/2006WO2006107941A1 DERIVATIVES OF [6,7-DIHYDRO-5HIMIDAZO [l,2-ALPHA] IMIDAZOLE-3-SULFONYL]-AZETEDINE-CARBOXYLIC ACIDS, ESTERS AND AMIDES AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS
10/12/2006WO2006107784A1 Imidazopyridazine compounds
10/12/2006WO2006107756A1 Pyrrolo [2,3-d] imidazoles for the treatment of hyperproliferative disorders
10/12/2006WO2006107644A1 Colorant compounds, intermediates, and compositions
10/12/2006WO2006106423A2 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
10/12/2006WO2006106090A1 Novel substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/12/2006WO2006105697A1 Piperidyl-2, 6-dione derivatives used to inhibit cells from releasing tumor necrosis factor
10/12/2006WO2006060225A3 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds
10/12/2006WO2005023760A3 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
10/12/2006US20060229456 Diazotizing a blocked 5-amino-1H-imidazole-4-carboxamide; hydrolysis; antitumor agents
10/12/2006US20060229449 Reacting with chloramine in presence of aqueous base, phase transfer catalyst; anti-cancer agents, kinase inhibitors
10/12/2006US20060229447 Constrained compounds as CGRP-receptor antagonists
10/12/2006US20060229342 TNF-a production inhibitors
10/12/2006US20060229329 Such as 2-anilino-4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)pyrimidine; antiproliferative agents; rheumatoid arthritis
10/12/2006US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006US20060229311 Isatine derivatives with neurotrophic activity
10/12/2006US20060229307 partial antagonists and partial agonists of vanilloid-1 receptor (VR1); N-(4-trifluoromethylphenyl)-2-(3-trifluoromethyl-2-pyridinyl)pyrido[2,3-d]pyridazin-5-amine; antiinflammatory and analgesic agent
10/12/2006US20060229302 Tricyclic indole derivatives and their use in the treatment of alzheimer's disease
10/12/2006US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006US20060229300 Method for the preparation of enantiomerically pure mirtazapine
10/12/2006US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues